J. Vignat
Oncology · 2002–2022
A researcher in the Science corpus: 15 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 85 citations into it
- Epidemiology — 60 citations into it
Whom J. Vignat trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Vignat's perspective
Ordered by how strongly the researchers J. Vignat trusts endorse each paper. Same corpus, a different order for every researcher.
- Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer (International Journal of Cancer)
- Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. (The Lancet Oncology)
- Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. (Journal of Infectious Diseases)
- HPV-associated Head and Neck Cancer: A Virus-related Cancer Epidemic – A Review of Epidemiology, Biology, Virus Detection and Issues in Management (The Lancet Oncology)
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
- Global trends in breast cancer incidence and mortality 1973-1997. (International Journal of Epidemiology)
- J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- Cancer statistics for the year 2020: An overview (International Journal of Cancer)
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. (Lancet Global Health)
- Breast-cancer screening--viewpoint of the IARC Working Group. (New England Journal of Medicine)
Their papers
- Current and future burden of breast cancer: Global statistics for 2020 and 2040 (2022) — 2,868 citations
- The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020. (2022) — 975 citations
- The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study (2022) — 658 citations
- Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN (2022) — 2,060 citations
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. (2022) — 1,155 citations
- Global burden of primary liver cancer in 2020 and predictions to 2040 (2022) — 1,853 citations
- Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative (2022) — 1,192 citations
- Global Burden of 5 Major Types Of Gastrointestinal Cancer (2020) — 1,740 citations
- Worldwide burden of cancer attributable to HPV by site, country and HPV type (2017) — 2,030 citations
- Global burden of cancers attributable to infections in 2012: a synthetic analysis. (2016) — 1,389 citations
- Global burden of gastric cancer attributable to Helicobacter pylori (2015) — 907 citations
- Global burden of human papillomavirus and related diseases. (2012) — 1,666 citations
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. (2012) — 2,302 citations
- The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study (2007) — 362 citations
- European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection (2002) — 1,840 citations